CoChat

The DOI matches its Crossref record; 80 of the 80 references it cites were found in a registry or an index.

Vascular and amyloid pathologies are independent predictors of cognitive decline in normal elderly

Open access

Abstract

Our primary objective was to investigate a biomarker driven model for the interrelationships between vascular disease pathology, amyloid pathology, and longitudinal cognitive decline in cognitively normal elderly subjects between 70 and 90 years of age. Our secondary objective was to investigate the beneficial effect of cognitive reserve on these interrelationships. We used brain amyloid-β load measured using Pittsburgh compound B positron emission tomography as a marker for amyloid pathology. White matter hyperintensities and brain infarcts were measured using fluid-attenuated inversion recovery magnetic resonance imaging as a marker for vascular pathology. We studied 393 cognitively normal elderly participants in the population-based Mayo Clinic Study of Aging who had a baseline 3 T fluid-attenuated inversion recovery magnetic resonance imaging assessment, Pittsburgh compound B positron emission tomography scan, baseline cognitive assessment, lifestyle measures, and at least one additional clinical follow-up. We classified subjects as being on the amyloid pathway if they had a global cortical amyloid-β load of ≥1.5 standard uptake value ratio and those on the vascular pathway if they had a brain infarct and/or white matter hyperintensities load ≥1.11% of total intracranial volume (which corresponds to the top 25% of white matter hyperintensities in an independent non-demented sample). We used a global cognitive z-score as a measure of cognition. We found no evidence that the presence or absence of vascular pathology influenced the presence or absence of amyloid pathology and vice versa, suggesting that the two processes seem to be independent. Baseline cognitive performance was lower in older individuals, in males, those with lower education/occupation, and those on the amyloid pathway. The rate of cognitive decline was higher in older individuals (P < 0.001) and those with amyloid (P = 0.0003) or vascular (P = 0.0037) pathologies. In those subjects with both vascular and amyloid pathologies, the effect of both pathologies on cognition was additive and not synergistic. For a 79-year-old subject, the predicted annual rate of global z-score decline was -0.02 if on neither pathway, -0.07 if on the vascular pathway, -0.08 if on the amyloid pathway and -0.13 if on both pathways. The main conclusions of this study were: (i) amyloid and vascular pathologies seem to be at least partly independent processes that both affect longitudinal cognitive trajectories adversely and are major drivers of cognitive decline in the elderly; and (ii) cognitive reserve seems to offset the deleterious effect of both pathologies on the cognitive trajectories.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/brain/awu393

Cites

80 of 80 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Illustration of the interrelationships investigated. We tested the following hypotheses: Arrow A investigates if the occurrence of one pathology influences the presence of the other (co-dependence is illustrated by the presence of arrow A and independence suggests the absence of arrow A). Arrow B indicates that the overall effect of cerebrovascular disease and Alzheimer’s disease on cognitive outcomes is additive (sum of arrows B), and Arrow C indicates that the overall effect of cerebrovascular disease and Alzheimer’s disease on cognitive outcomes is synergistic. Arrow D indicates the influence of high versus low cognitive reserve protect against the deleterious effects of Alzheimer’s disease pathophysiology and cerebrovascular disease pathologies.
Figure 1 Illustration of the interrelationships investigated. We tested the following hypotheses: Arrow A investigates if the occurrence of one pathology influences the presence of the other (co-dependence is illustrated by the presence of arrow A and independence suggests the absence of arrow A). Arrow B indicates that the overall effect of cerebrovascular disease and Alzheimer’s disease on cognitive outcomes is additive (sum of arrows B), and Arrow C indicates that the overall effect of cerebrovascular disease and Alzheimer’s disease on cognitive outcomes is synergistic. Arrow D indicates the influence of high versus low cognitive reserve protect against the deleterious effects of Alzheimer’s disease pathophysiology and cerebrovascular disease pathologies.CC BY-NC · PubMed Central
Figure 2 Decrease in predicted cognitive scores with pathway in female (A) and male (B) subjects.
Figure 2 Decrease in predicted cognitive scores with pathway in female (A) and male (B) subjects.CC BY-NC · PubMed Central
Figure 3 Decrease in predicted cognitive scores with pathway stratified by subjects with high cognitive reserve (75th percentile of education/occupation scores) and low cognitive reserve (25th percentile of education/occupation scores).
Figure 3 Decrease in predicted cognitive scores with pathway stratified by subjects with high cognitive reserve (75th percentile of education/occupation scores) and low cognitive reserve (25th percentile of education/occupation scores).CC BY-NC · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

1 more claim about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 1

  1. Senjem, 2008, Automated ROI analysis of 11C Pittsburgh compound B images using structural magnetic resonance imaging atlases, Alzheimer's and Dementia. Alzheimer's Association International Conference on Alzheimer's Disease

Cited by

See all 299

Metadata

Authors
Vemuri, P., Lesnick, T. G., Przybelski, S. A., Knopman, D. S., Preboske, G. M., Kantarci, K., Raman, M. R., Machulda, M. M., Mielke, M. M., Lowe, V. J., Senjem, M. L., Gunter, J. L., Rocca, W. A., Roberts, R. O., Petersen, R. C., & Jack, C. R.
Affiliations
Mayo Clinic (US)
Corresponding author
Vemuri, Prashanthi
Venue
Brain
Published
2015-01-13
Volume
138
Issue
3
Pages
761-771
ISSN
  • 0006-8950 (ISSN-L)
  • 1460-2156
OpenAlex
W2096197732
Cited by
299
References
80
Citations by year
2026: 22 · 2025: 19 · 2024: 23 · 2023: 20 · 2022: 30 · 2021: 22 · 2020: 35 · 2019: 31 · 2018: 33 · 2017: 25 · 2016: 31 · 2015: 7
FWCI
25.83
Type
journal article
Language
en
Open access
Licence
cc-by-nc
Locations
  • Brain (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health (UL1TR000135)
  • National Institute on Aging (R01AG034676, U01AG006786, K99AG037573, R01AG011378, R01AG041851, R00AG037573, P50AG016574)
  • National Center for Research Resources (C06RR018898)
  • National Center for Advancing Translational Sciences
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Keywords
cognitive decline, amyloid pathology, vascular pathology, white matter hyperintensities, cerebral infarction, cognitive reserve, Pittsburgh compound B, FLAIR, cognitively normal elderly, Mayo Clinic Study of Aging, biomarkers, brain aging, education and cognition, sex differences in cognition
MeSH terms
Aged, Aged, 80 and over, Aging, Alzheimer Disease, Analysis of Variance, Aniline Compounds, Cerebrovascular Disorders, Cognition Disorders, Female, Humans, Magnetic Resonance Imaging, Male, Neuropsychological Tests, Predictive Value of Tests, Thiazoles, Tomography Scanners, X-Ray Computed, Amyloid beta-Peptides, Positron-Emission Tomography

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.